Medicaid Provider Spending

$1.09 trillion in Medicaid claims data, 2018–2024 · 617K+ providers
Home › WV › MARTINSBURG › CITY HOSPITAL, INC

CITY HOSPITAL, INC

NPI: 1457389249 · MARTINSBURG, WV 25401 · General Acute Care Hospital · NPI assigned 06/29/2006

$41.06M
Total Medicaid Paid
1,114,527
Total Claims
905,020
Beneficiaries
454
Codes Billed
2018-01
First Month
2024-12
Last Month

Provider Details

Authorized OfficialQUINONES, KATHLEEN (VP OF FINANCE)
Parent OrganizationWEST VIRGINIA UNIVERSITY HOSPITALS EAST INC
NPI Enumeration Date06/29/2006

Related Entities

Other providers sharing the same authorized official: QUINONES, KATHLEEN

ProviderCityStateTotal Paid
BILLINGS CLINIC BILLINGS MT $53.85M
JEFFERSON MEMORIAL HOSPITAL RANSON WV $21.65M
BILLINGS CLINIC BILLINGS MT $15.71M
BILLINGS CLINIC BILLINGS MT $3.32M
BILLINGS CLINIC BILLINGS MT $2.99M
BILLINGS CLINIC BILLINGS MT $2.40M
BILLINGS CLINIC CODY WY $110K
BILLINGS CLINIC BILLINGS MT $97K
BILLINGS CLINIC BILLINGS MT $20K
BILLINGS CLINIC LIVINGSTON MT $2K

Monthly Spending Trend

Yearly Breakdown

YearClaimsTotal Paid
2018 193,129 $9.06M
2019 119,836 $5.42M
2020 221,032 $8.77M
2021 207,029 $5.40M
2022 109,186 $3.44M
2023 134,757 $4.39M
2024 129,558 $4.58M

Billing Codes

CodeDescriptionClaimsBeneficiariesTotal Paid
99285 Emergency department visit for the evaluation and management, high severity with immediate threat to life 16,609 14,111 $5.96M
99284 Emergency department visit for the evaluation and management, high severity 39,201 33,826 $5.61M
99283 Emergency department visit for the evaluation and management, moderate severity 43,968 38,989 $3.67M
80053 Comprehensive metabolic panel 81,820 66,823 $1.11M
80307 Drug test(s), presumptive, any number of drug classes; immunoassay 19,687 15,380 $1.06M
85025 Blood count; complete (CBC), automated, and automated differential WBC count 91,185 72,529 $1.05M
74177 Computed tomography, abdomen and pelvis; with contrast material 5,942 5,181 $934K
99282 Emergency department visit for the evaluation and management, low to moderate severity 15,943 14,593 $751K
97110 Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion 20,074 5,922 $706K
96413 Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance 4,788 2,448 $665K
U0004 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r 8,264 7,485 $558K
74176 Computed tomography, abdomen and pelvis; without contrast material 6,250 5,619 $472K
87637 Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV 4,641 4,247 $470K
96374 Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance 18,362 15,080 $436K
96372 Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular 14,847 10,095 $358K
84443 Thyroid stimulating hormone (TSH) 21,049 18,964 $348K
96365 Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour 7,244 5,069 $334K
93306 Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete 2,982 2,731 $326K
36415 Collection of venous blood by venipuncture 33,762 26,915 $300K
87651 Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe 8,228 7,655 $285K
93005 Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report 29,994 25,409 $282K
99212 Office or other outpatient visit for the evaluation and management of an established patient, straightforward 15,951 14,517 $278K
88305 Level IV - Surgical pathology, gross and microscopic examination 4,124 3,707 $275K
96375 Therapeutic injection; each additional sequential IV push 16,531 12,065 $271K
92507 Treatment of speech, language, voice, communication, and/or auditory processing disorder 5,129 2,019 $258K
J2405 Injection, ondansetron hydrochloride, per 1 mg 11,701 8,653 $256K
70450 Computed tomography, head or brain; without contrast material 4,556 4,071 $250K
87631 2,508 2,297 $247K
84484 18,922 14,936 $247K
97530 Therapeutic activities, direct patient contact, each 15 minutes 5,562 2,132 $242K
G0378 Hospital observation service, per hour 4,693 1,781 $240K
71045 Radiologic examination, chest; single view 12,820 11,101 $234K
G0463 Hospital outpatient clinic visit for assessment and management of a patient 7,116 5,936 $230K
81001 22,409 19,198 $223K
J1100 Injection, dexamethasone sodium phosphate, 1 mg 12,202 9,417 $217K
83735 7,808 5,443 $181K
71275 Computed tomographic angiography, chest, with contrast material 1,623 1,409 $176K
78452 Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress 573 502 $167K
87633 Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets 1,033 945 $166K
83690 15,325 13,142 $163K
41899 Unlisted procedure, dentoalveolar structures 143 132 $163K
71046 Radiologic examination, chest; 2 views 7,246 6,684 $162K
77067 Screening mammography, bilateral, including computer-aided detection 2,306 2,175 $161K
J2250 Injection, midazolam hydrochloride, per 1 mg 4,937 4,265 $153K
87591 Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe 5,108 4,579 $153K
87491 Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe 5,104 4,576 $153K
97140 Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) 6,887 2,474 $150K
G0480 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed 1,549 1,138 $149K
U0002 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc 3,694 3,277 $148K
81025 10,620 9,139 $144K
J7060 5% dextrose/water (500 ml = 1 unit) 2,032 620 $139K
76705 Ultrasound, abdominal, real time with image documentation; limited 2,613 2,385 $138K
0202U Oncology (prostate), multianalyte, gene expression profiling 4,646 4,261 $135K
72148 Magnetic resonance imaging, lumbar spine; without contrast material 936 891 $135K
Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml 11,347 9,765 $133K
80061 Lipid panel 8,295 7,871 $129K
43239 Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple 669 613 $128K
76830 Ultrasound, transvaginal 1,708 1,555 $124K
J0131 Injection, acetaminophen, not otherwise specified,10 mg 3,679 3,113 $120K
87086 Culture, bacterial; quantitative colony count, urine 10,053 8,866 $119K
96376 3,706 2,057 $119K
J1885 Injection, ketorolac tromethamine, per 15 mg 10,484 8,548 $117K
45380 Colonoscopy, flexible; with biopsy, single or multiple 340 311 $113K
96366 Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour 2,177 1,270 $109K
81003 11,966 10,554 $106K
93971 1,704 1,573 $103K
71250 2,114 1,942 $101K
87661 Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe 3,346 2,996 $98K
84702 6,615 5,394 $97K
J0690 Injection, cefazolin sodium, 500 mg 1,873 1,413 $96K
73721 Magnetic resonance imaging, any joint of lower extremity; without contrast material 580 538 $95K
70553 Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences 512 459 $93K
80048 Basic metabolic panel (calcium, ionized) 7,651 6,198 $93K
72125 Computed tomography, cervical spine; without contrast material 1,522 1,359 $93K
85610 7,971 6,545 $93K
96367 2,811 1,577 $93K
0099U 538 485 $92K
82306 Vitamin D; 25 hydroxy, includes fraction(s), if performed 3,442 3,282 $86K
97162 1,859 1,761 $85K
70551 Magnetic resonance imaging, brain; without contrast material 752 675 $82K
96361 Intravenous infusion, hydration; each additional hour 4,878 3,758 $81K
86140 6,266 5,463 $78K
76641 1,335 1,182 $78K
87522 Neg quan hep c or qual rna 1,562 1,461 $77K
J1642 Injection, heparin sodium, (heparin lock flush), per 10 units 6,320 3,464 $76K
83036 Hemoglobin; glycosylated (A1C) 6,825 6,445 $75K
78815 Positron emission tomography (PET) for limited area imaging 209 194 $74K
J2785 Injection, regadenoson, 0.1 mg 462 394 $74K
A9500 Technetium tc-99m sestamibi, diagnostic, per study dose 618 540 $69K
90471 Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine 3,646 3,325 $69K
85027 3,982 3,280 $69K
72131 1,025 940 $67K
76856 Ultrasound, pelvic (nonobstetric), real time with image documentation; complete 1,050 969 $66K
87507 257 239 $66K
71260 Computed tomography, thorax, diagnostic; with contrast material 736 622 $65K
96415 895 585 $64K
88304 947 834 $64K
94640 Pressurized or nonpressurized inhalation treatment for acute airway obstruction 4,631 3,154 $64K
82607 3,442 3,254 $64K
86850 4,693 4,036 $63K
95811 107 98 $62K
93017 715 630 $62K
76801 1,102 917 $61K
80050 General health panel 1,563 1,460 $61K
97161 1,140 1,065 $60K
J2270 Injection, morphine sulfate, up to 10 mg 1,672 1,254 $60K
83880 2,932 2,543 $59K
72141 319 308 $58K
87653 1,731 1,621 $58K
84439 3,670 3,375 $57K
90837 Psychotherapy, 53 minutes with patient 601 392 $57K
82728 3,602 3,343 $56K
80074 1,298 1,229 $55K
77063 Screening digital breast tomosynthesis, bilateral 2,003 1,885 $55K
83605 3,416 2,728 $55K
86901 4,908 4,132 $54K
86900 4,902 4,133 $52K
87040 2,763 1,822 $52K
87502 Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets 834 754 $51K
64483 195 170 $51K
11042 Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm 430 286 $50K
99211 Office or other outpatient visit for the evaluation and management of an established patient, minimal severity 3,211 2,939 $50K
87186 3,909 3,530 $49K
70486 608 577 $48K
93975 427 394 $47K
85730 4,098 3,470 $45K
93970 459 422 $43K
87340 2,185 2,031 $42K
86803 2,247 2,111 $42K
85007 2,231 1,734 $42K
U0005 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 2,266 2,114 $40K
87798 Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism 515 465 $40K
64493 187 153 $40K
87486 482 436 $40K
76700 Ultrasound, abdominal, real time with image documentation; complete 461 436 $39K
87581 481 435 $39K
97112 Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination 1,336 557 $39K
93303 Transthoracic echocardiography for congenital cardiac anomalies, follow-up or limited study 232 227 $38K
96360 Intravenous infusion, hydration; initial, 31 minutes to 1 hour 1,634 1,373 $38K
84466 3,038 2,820 $37K
76536 561 525 $37K
59025 Fetal non-stress test 1,776 1,025 $36K
97113 995 338 $36K
87389 Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies 1,578 1,461 $35K
88312 515 475 $35K
0097U 431 395 $34K
86780 2,310 2,166 $34K
99281 Emergency department visit for the evaluation and management, self-limited or minor 1,624 1,504 $34K
87624 Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types 1,087 909 $33K
87070 2,100 1,838 $33K
76817 Ultrasound, pregnant uterus, real time with image documentation, transvaginal 773 655 $32K
J0330 Injection, succinylcholine chloride, up to 20 mg 856 730 $32K
99392 Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) 701 660 $31K
82565 1,427 1,191 $30K
73630 1,318 1,163 $30K
84703 1,236 1,113 $30K
85651 2,748 2,494 $29K
94060 629 604 $29K
10060 402 360 $29K
J0780 Injection, prochlorperazine, up to 10 mg 3,092 2,524 $29K
82746 1,529 1,446 $27K
87077 2,355 2,129 $27K
76775 497 473 $27K
73130 1,039 887 $27K
72110 939 903 $27K
82550 1,932 1,564 $26K
73564 1,006 880 $26K
A9576 Injection, gadoteridol, (prohance multipack), per ml 1,100 976 $26K
96523 1,413 1,145 $26K
85379 1,709 1,527 $26K
83540 3,184 2,959 $26K
J1200 Injection, diphenhydramine hcl, up to 50 mg 4,603 3,410 $25K
86706 1,045 978 $25K
73610 1,047 934 $24K
88142 1,391 1,203 $24K
96417 355 185 $24K
84145 1,366 1,138 $24K
C9803 Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source 2,761 2,151 $23K
J0696 Injection, ceftriaxone sodium, per 250 mg 2,230 1,599 $23K
86618 1,085 669 $23K
84112 282 234 $22K
81513 192 176 $22K
74018 1,020 933 $22K
97014 1,471 577 $22K
90715 617 577 $22K
90472 Immunization administration, each additional vaccine (list separately) 1,314 1,222 $21K
0241U Neonatal screening for hereditary disorders, genomic sequence analysis panel 1,697 1,458 $21K
87210 1,431 1,071 $21K
84100 1,868 1,368 $21K
J1745 Injection, infliximab, excludes biosimilar, 10 mg 13 12 $21K
73030 1,179 1,065 $21K
J1756 Injection, iron sucrose, 1 mg 678 241 $21K
J2060 Injection, lorazepam, 2 mg 1,788 1,209 $21K
99291 Critical care, evaluation and management of the critically ill patient, first 30-74 minutes 178 152 $20K
88307 239 181 $20K
J1439 Injection, ferric carboxymaltose, 1 mg 41 27 $20K
83516 757 616 $20K
J2001 Injection, lidocaine hcl for intravenous infusion, 10 mg 3,123 2,677 $20K
77066 Tomosynthesis, mammo 301 288 $20K
82570 1,977 1,787 $20K
93271 247 229 $19K
12001 230 217 $19K
86255 619 580 $18K
J1644 Injection, heparin sodium, per 1000 units 2,017 966 $18K
87088 1,128 1,030 $18K
Q9957 Injection, perflutren lipid microspheres, per ml 223 185 $18K
93925 162 160 $17K
95806 297 287 $17K
87641 639 595 $17K
94729 410 389 $16K
87205 1,492 1,269 $16K
86038 864 833 $16K
93320 233 228 $16K
G0475 Hiv antigen/antibody, combination assay, screening 1,444 1,371 $16K
76770 393 373 $16K
J1650 Injection, enoxaparin sodium, 10 mg 1,563 641 $16K
J2765 Injection, metoclopramide hcl, up to 10 mg 942 786 $15K
Q3014 Telehealth originating site facility fee 698 581 $15K
99393 Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) 303 294 $15K
J2550 Injection, promethazine hcl, up to 50 mg 842 670 $14K
93325 245 240 $14K
84550 1,124 940 $14K
73110 460 414 $14K
82150 295 275 $14K
J3475 Injection, magnesium sulfate, per 500 mg 1,759 1,320 $14K
99391 Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) 362 334 $14K
99213 Office or other outpatient visit for the evaluation and management of an established patient, low complexity 1,016 943 $14K
92557 654 623 $13K
86762 723 657 $13K
80076 1,111 1,042 $13K
84153 487 461 $13K
86308 801 717 $12K
94726 377 356 $12K
93978 114 112 $12K
82784 562 396 $12K
86431 636 611 $12K
73502 551 505 $12K
96411 231 135 $12K
87147 922 840 $12K
83615 911 719 $12K
81329 83 77 $12K
76819 Fetal biophysical profile; without non-stress testing 91 63 $12K
C1769 Guide wire 578 499 $11K
20610 128 116 $11K
84156 1,029 834 $11K
82043 1,099 1,059 $11K
87481 391 322 $11K
83970 395 374 $11K
12011 154 142 $11K
U0003 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r 184 168 $11K
87081 912 884 $11K
90791 Psychiatric diagnostic evaluation 101 94 $10K
45378 Colonoscopy, flexible; diagnostic, including collection of specimen(s) 106 89 $10K
82803 381 300 $10K
81596 128 122 $10K
J2790 Injection, rho d immune globulin, human, full dose, 300 micrograms (1500 i.u.) 141 133 $10K
87902 74 72 $10K
J2930 Injection, methylprednisolone sodium succinate, up to 125 mg 1,010 823 $10K
93976 116 104 $10K
77002 190 167 $10K
81220 CFTR (cystic fibrosis transmembrane conductance regulator) gene analysis; common variants 115 103 $9K
76870 164 147 $9K
84403 371 345 $9K
29125 92 81 $9K
82248 1,044 896 $9K
70491 164 131 $9K
82977 386 352 $9K
86704 363 354 $9K
J2704 Injection, propofol, 10 mg 3,973 3,394 $8K
73221 105 95 $8K
90671 470 432 $8K
86480 150 145 $8K
86003 88 81 $8K
82950 895 846 $8K
84520 1,158 966 $8K
82140 238 201 $7K
83883 250 232 $7K
86790 250 241 $7K
84146 330 302 $7K
97116 490 219 $7K
92567 1,167 1,106 $7K
80069 591 511 $7K
72100 218 198 $6K
86376 342 327 $6K
82172 216 200 $6K
83010 219 203 $6K
J1453 Injection, fosaprepitant, 1 mg 125 55 $6K
J3301 Injection, triamcinolone acetonide, not otherwise specified, 10 mg 788 679 $6K
J2710 Injection, neostigmine methylsulfate, up to 0.5 mg 206 150 $6K
82247 545 358 $6K
J1630 Injection, haloperidol, up to 5 mg 343 274 $6K
87635 Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe 123 107 $6K
45385 Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s) 14 14 $6K
93798 715 130 $5K
82272 268 243 $5K
73140 180 168 $5K
P9612 Catheterization for collection of specimen, single patient, all places of service 154 141 $5K
86787 389 361 $5K
J2469 Injection, palonosetron hcl, 25 mcg 256 131 $5K
95813 25 25 $5K
84460 370 289 $5K
96110 Developmental screening, with scoring and documentation, per standardized instrument 573 533 $5K
G0279 Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066) 255 244 $5K
92587 132 121 $5K
82010 599 468 $5K
72040 184 174 $5K
99202 Office or other outpatient visit for the evaluation and management of a new patient, straightforward 667 649 $4K
83655 229 216 $4K
92551 589 565 $4K
73560 209 176 $4K
88185 49 45 $4K
86200 83 81 $4K
36600 98 77 $4K
A9552 Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries 246 224 $4K
J2370 Injection, phenylephrine hcl, up to 1 ml 57 44 $4K
76805 Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation 25 24 $4K
71271 72 71 $4K
73562 307 224 $4K
93270 246 228 $3K
81015 584 538 $3K
95800 136 133 $3K
27096 12 12 $3K
G0260 Injection procedure for sacroiliac joint; provision of anesthetic, steroid and/or other therapeutic agent, with or without arthrography 92 90 $3K
82105 99 94 $3K
97164 84 78 $3K
93923 55 51 $3K
93225 54 52 $3K
83001 142 135 $3K
90686 220 176 $3K
C1729 Catheter, drainage 60 26 $2K
70496 58 49 $2K
72072 103 96 $2K
90832 Psychotherapy, 30 minutes with patient 36 36 $2K
59430 27 26 $2K
93226 54 52 $2K
G0108 Diabetes outpatient self-management training services, individual, per 30 minutes 34 24 $2K
49083 33 13 $2K
84165 124 120 $2K
74178 13 13 $2K
94664 116 108 $2K
90723 253 237 $2K
97165 45 42 $2K
76816 Ultrasound, pregnant uterus, real time with image documentation, follow-up 41 41 $2K
51798 413 382 $2K
82103 28 26 $2K
90833 Psychotherapy, 30 minutes with patient when performed with an E&M service (add-on) 45 38 $2K
Q0162 Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen 2,050 1,401 $2K
73100 16 14 $2K
97166 56 53 $2K
92579 48 45 $2K
J1170 Injection, hydromorphone, up to 4 mg 1,286 874 $2K
J3360 Injection, diazepam, up to 5 mg 126 105 $2K
80179 98 85 $2K
88184 49 45 $1K
86160 39 37 $1K
J0171 Injection, adrenalin, epinephrine, 0.1 mg 128 104 $1K
73090 60 55 $1K
86920 31 26 $1K
90792 Psychiatric diagnostic evaluation with medical services 16 13 $1K
G0481 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 8-14 drug class(es), including metabolite(s) if performed 13 12 $1K
C1894 Introducer/sheath, other than guiding, other than intracardiac electrophysiological, non-laser 95 89 $1K
84450 196 140 $1K
83002 56 52 $1K
83520 52 50 $1K
90656 243 231 $1K
J2543 Injection, piperacillin sodium/tazobactam sodium, 1 gram/0.125 grams (1.125 grams) 147 87 $1K
87529 22 13 $1K
72202 40 40 $1K
J3490 Unclassified drugs 6,116 2,915 $1K
73080 56 53 $1K
72052 30 29 $1K
90474 141 136 $1K
72050 38 38 $1K
74183 14 14 $965.23
86592 37 30 $962.09
74221 38 25 $955.43
90636 13 12 $929.83
90746 31 28 $926.58
J7512 Prednisone, immediate release or delayed release, oral, 1 mg 1,450 1,115 $917.29
73590 56 51 $915.12
80164 62 56 $912.98
J2780 Injection, ranitidine hydrochloride, 25 mg 29 24 $880.36
80055 25 25 $877.03
84402 26 26 $807.94
80143 58 52 $803.81
80051 65 37 $803.78
99395 Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years 13 13 $775.77
73700 12 12 $758.84
99394 Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) 13 13 $751.20
87804 Infectious agent antigen detection by immunoassay; Influenza, each type 26 21 $745.10
72114 33 29 $716.20
J3010 Injection, fentanyl citrate, 0.1 mg 2,217 1,981 $714.26
76882 43 38 $695.42
82947 72 67 $695.32
82525 27 24 $693.84
90658 32 29 $657.19
86769 18 17 $638.57
84075 82 50 $633.44
90710 16 15 $628.72
76811 Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation, detailed 13 13 $601.13
82390 25 25 $599.04
97035 25 12 $587.50
99203 Office or other outpatient visit for the evaluation and management of a new patient, low complexity 91 88 $533.97
C1725 Catheter, transluminal angioplasty, non-laser (may include guidance, infusion/perfusion capability) 12 12 $530.39
J3370 Injection, vancomycin hcl, 500 mg 61 39 $513.03
85018 151 121 $511.33
36592 16 14 $480.00
72081 18 17 $476.97
86677 17 16 $458.98
83021 27 26 $450.22
73070 13 12 $425.74
83020 27 26 $416.27
87807 15 13 $400.83
G0010 Administration of hepatitis b vaccine 14 12 $394.54
73620 39 28 $347.54
90680 85 83 $301.65
73600 140 24 $240.90
J3105 Injection, terbutaline sulfate, up to 1 mg 89 69 $237.57
77080 13 13 $231.04
J1940 Injection, furosemide, up to 20 mg 34 29 $218.07
80178 12 12 $207.92
80306 29 25 $196.94
J0134 Injection, acetaminophen (fresenius kabi), not therapeutically equivalent to j0131, 10 mg 258 229 $164.48
88342 30 26 $161.98
94010 14 13 $145.32
90648 423 396 $125.80
82962 75 72 $123.89
96127 44 42 $118.80
70498 16 13 $117.06
G8979 Mobility: walking & moving around functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting 28 28 $113.14
A9585 Injection, gadobutrol, 0.1 ml 58 56 $109.02
86705 25 25 $108.76
Q0163 Diphenhydramine hydrochloride, 50 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at time of chemotherapy treatment not to exceed a 48 hour dosage regimen 15 12 $85.79
85652 48 41 $64.35
36416 118 115 $60.80
J2919 Injection, methylprednisolone sodium succinate, 5 mg 101 69 $53.24
G1010 Clinical decision support mechanism stanson, as defined by the medicare appropriate use criteria program 788 675 $36.67
J3480 Injection, potassium chloride, per 2 meq 47 26 $29.95
99173 13 12 $28.22
99459 66 61 $25.00
J1790 Injection, droperidol, up to 5 mg 102 92 $14.11
99001 43 39 $11.40
Q0177 Hydroxyzine pamoate, 25 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen 129 94 $11.14
J0137 Injection, acetaminophen (hikma), not therapeutically equivalent to j0131, 10 mg 70 51 $7.98
C1751 Catheter, infusion, inserted peripherally, centrally or midline (other than hemodialysis) 56 47 $3.96
J1171 Injection, hydromorphone, 0.1 mg 40 29 $1.35
J1815 Injection, insulin, per 5 units 33 26 $0.56
J0136 Injection, acetaminophen (b braun), not therapeutically equivalent to j0131, 10 mg 62 54 $0.00
90633 38 38 $0.00
90653 21 21 $0.00
G8978 Mobility: walking & moving around functional limitation, current status, at therapy episode outset and at reporting intervals 13 13 $0.00
99172 109 109 $0.00
J2003 Injection, lidocaine hydrochloride, 1 mg 39 35 $0.00
V2632 Posterior chamber intraocular lens 13 12 $0.00